Neil Floch MD FACS FASMBS DABOM
@neilflochmd.bsky.social
Bariatric and Foregut Surgeon passionate about educating and advocating about obesity causes and treatments including medications and bariatric surgery - Associate Professor of Surgery Yale School of Medicine and a self-taught artist - Tufts Graduate
American Society for Metabolic and Bariatric Surgery review of the body mass index #obesity #bariatricsurgery #SOARD www.soard.org/article/S155...
American Society for Metabolic and Bariatric Surgery review of the body mass index
The body mass index was first described almost 200 years ago and has since been used
as a measure of obesity. This review describes the history, advantages, disadvantages,
and alternatives to the body...
www.soard.org
November 4, 2025 at 12:34 AM
American Society for Metabolic and Bariatric Surgery review of the body mass index #obesity #bariatricsurgery #SOARD www.soard.org/article/S155...
Intussusception is a condition or complication where one part of the intestine telescopes into another. It can occur from a mass of the bowel such as a polyp or growth or from fixed point such as in bowel or gastric bypass surgery. #obesity #pediatric surgery #gastricbypass
November 3, 2025 at 5:47 PM
Intussusception is a condition or complication where one part of the intestine telescopes into another. It can occur from a mass of the bowel such as a polyp or growth or from fixed point such as in bowel or gastric bypass surgery. #obesity #pediatric surgery #gastricbypass
The Yale Obesity Symposium
A one-day 7 CME event
November 21 2025
NEW developments in
Obesity Treatment
Speakers including:
Lee Kaplan MD PhD
Ania Jastreboff MD PhD
John Morton MD
Register NOW! cme.edu
@Yale @YaleMed @YaleSurgery
Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1
A one-day 7 CME event
November 21 2025
NEW developments in
Obesity Treatment
Speakers including:
Lee Kaplan MD PhD
Ania Jastreboff MD PhD
John Morton MD
Register NOW! cme.edu
@Yale @YaleMed @YaleSurgery
Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1
October 18, 2025 at 1:25 PM
The Yale Obesity Symposium
A one-day 7 CME event
November 21 2025
NEW developments in
Obesity Treatment
Speakers including:
Lee Kaplan MD PhD
Ania Jastreboff MD PhD
John Morton MD
Register NOW! cme.edu
@Yale @YaleMed @YaleSurgery
Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1
A one-day 7 CME event
November 21 2025
NEW developments in
Obesity Treatment
Speakers including:
Lee Kaplan MD PhD
Ania Jastreboff MD PhD
John Morton MD
Register NOW! cme.edu
@Yale @YaleMed @YaleSurgery
Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1
Reposted by Neil Floch MD FACS FASMBS DABOM
I lost 160 pounds, here is a side by side comparison of my swing
https://www.fogolf.com/952118/i-lost-160-pounds-here-is-a-side-by-side-comparison-of-my-swing/
I had gastric bypass surgery in June of 2024, I had quit golf completely and sold my clubs because I thought I wouldn’t be able to play …
https://www.fogolf.com/952118/i-lost-160-pounds-here-is-a-side-by-side-comparison-of-my-swing/
I had gastric bypass surgery in June of 2024, I had quit golf completely and sold my clubs because I thought I wouldn’t be able to play …
I lost 160 pounds, here is a side by side comparison of my swing
I had gastric bypass surgery in June of 2024, I had quit golf completely and sold my clubs because I thought I wouldn’t be able to play again. by naughtyasf143
www.fogolf.com
April 30, 2025 at 3:30 PM
I lost 160 pounds, here is a side by side comparison of my swing
https://www.fogolf.com/952118/i-lost-160-pounds-here-is-a-side-by-side-comparison-of-my-swing/
I had gastric bypass surgery in June of 2024, I had quit golf completely and sold my clubs because I thought I wouldn’t be able to play …
https://www.fogolf.com/952118/i-lost-160-pounds-here-is-a-side-by-side-comparison-of-my-swing/
I had gastric bypass surgery in June of 2024, I had quit golf completely and sold my clubs because I thought I wouldn’t be able to play …
Reposted by Neil Floch MD FACS FASMBS DABOM
From our September issue: Bile acids in the crosshairs for hypoglycaemia after gastric bypass, a News & Views from Marzieh Salehi (£) bit.ly/3H6tHhG #EndoSky #MedSky
August 12, 2025 at 12:47 PM
From our September issue: Bile acids in the crosshairs for hypoglycaemia after gastric bypass, a News & Views from Marzieh Salehi (£) bit.ly/3H6tHhG #EndoSky #MedSky
Reposted by Neil Floch MD FACS FASMBS DABOM
Enough is enough. The health of the country is in danger. Read our resignation letters: insidemedicine.substack.com/p/breaking-n...
Breaking News: Read three top CDC officials' resignation emails.
The end of an era.
insidemedicine.substack.com
August 28, 2025 at 3:38 AM
Enough is enough. The health of the country is in danger. Read our resignation letters: insidemedicine.substack.com/p/breaking-n...
Revisional Bariatric Surgery in The Elderly: A Comprehensive Review of the Safety and Efficacy Profile - Surgery for Obesity and Related Diseases www.soard.org/article/S155... #SOARD #bariatricsurgery #obesity
Revisional Bariatric Surgery in The Elderly: A Comprehensive Review of the Safety and Efficacy Profile
Despite the well-known safety and efficacy of metabolic and bariatric surgery (MBS),
certain patients require revisional bariatric surgery (RBS) due to weight-related
and/or procedure-related complica...
www.soard.org
August 26, 2025 at 11:20 AM
Revisional Bariatric Surgery in The Elderly: A Comprehensive Review of the Safety and Efficacy Profile - Surgery for Obesity and Related Diseases www.soard.org/article/S155... #SOARD #bariatricsurgery #obesity
The Impact of Bariatric Surgery on Cardiovascular Risk Factors and Outcomes: A Systematic Review | Cureus
x.com/neilflochmd/...
x.com/neilflochmd/...
x.com
August 12, 2025 at 6:17 PM
The Impact of Bariatric Surgery on Cardiovascular Risk Factors and Outcomes: A Systematic Review | Cureus
x.com/neilflochmd/...
x.com/neilflochmd/...
Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity
x.com/soard_journa...
x.com/soard_journa...
SOARD Journal on X: "Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity https://t.co/THiNjGTHAR" / X
Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity https://t.co/THiNjGTHAR
x.com
August 12, 2025 at 6:16 PM
Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity
x.com/soard_journa...
x.com/soard_journa...
Single-anastomosis duodenal-ileal bypass with sleeve gastrectomy for diabetes: predictors of remission and metabolic outcomes in a multicenter study - Surgery for Obesity and Related Diseases www.soard.org/article/S155...
Single-anastomosis duodenal-ileal bypass with sleeve gastrectomy for diabetes: predictors of remission and metabolic outcomes in a multicenter study
The single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) combines
the restrictive aspects of a sleeve gastrectomy (SG) with the hypoabsorptive advantages
of a gastric bypass. SADI...
www.soard.org
July 21, 2025 at 10:57 AM
Single-anastomosis duodenal-ileal bypass with sleeve gastrectomy for diabetes: predictors of remission and metabolic outcomes in a multicenter study - Surgery for Obesity and Related Diseases www.soard.org/article/S155...
GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study - Surgery for Obesity and Related Diseases www.soard.org/article/S155...
GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study
Whether preoperative exposure to glucagon-like peptide-1 receptor agonists (GLP-1
RAs) are associated with postoperative nausea and vomiting (PONV) after laparoscopic
sleeve gastrectomy (LSG) remains ...
www.soard.org
April 23, 2025 at 11:46 AM
GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study - Surgery for Obesity and Related Diseases www.soard.org/article/S155...
Weight stigma asa barrier to care www.medscape.com/viewarticle/...
Weight Stigma Remains a Barrier to Patient Care
Patients with obesity often report being shamed and stigmatized in medical settings. How can physicians address weight sensitively?
www.medscape.com
April 20, 2025 at 9:29 PM
Weight stigma asa barrier to care www.medscape.com/viewarticle/...
Reposted by Neil Floch MD FACS FASMBS DABOM
Oral semaglutide cost-effective vs. liraglutide—even at 50% ⤵️ price
🔹 🇬🇧 modelled data: ⤴️ QALYs (+0.18) & ⤵️ comp.
🔸 💊 = ⤵️ Rx burden vs. daily 💉
🔹 Results robust across sensitivity analyses
⚠️ funded by NovoNordisk
👉 Challenges low-cost liraglutide, supports 🎯 oral GLP-1 use
🔗 ggdocs.co/9h0bz1
🔹 🇬🇧 modelled data: ⤴️ QALYs (+0.18) & ⤵️ comp.
🔸 💊 = ⤵️ Rx burden vs. daily 💉
🔹 Results robust across sensitivity analyses
⚠️ funded by NovoNordisk
👉 Challenges low-cost liraglutide, supports 🎯 oral GLP-1 use
🔗 ggdocs.co/9h0bz1
March 21, 2025 at 12:45 PM
Oral semaglutide cost-effective vs. liraglutide—even at 50% ⤵️ price
🔹 🇬🇧 modelled data: ⤴️ QALYs (+0.18) & ⤵️ comp.
🔸 💊 = ⤵️ Rx burden vs. daily 💉
🔹 Results robust across sensitivity analyses
⚠️ funded by NovoNordisk
👉 Challenges low-cost liraglutide, supports 🎯 oral GLP-1 use
🔗 ggdocs.co/9h0bz1
🔹 🇬🇧 modelled data: ⤴️ QALYs (+0.18) & ⤵️ comp.
🔸 💊 = ⤵️ Rx burden vs. daily 💉
🔹 Results robust across sensitivity analyses
⚠️ funded by NovoNordisk
👉 Challenges low-cost liraglutide, supports 🎯 oral GLP-1 use
🔗 ggdocs.co/9h0bz1
Reposted by Neil Floch MD FACS FASMBS DABOM
📢 #GLP1 ⤵️ kidney decline, CV events & mortality in CKD❗️
🔹 Meta-analysis of 18K pts w/ eGFR <60:
⤵️ eGFR decline ≥50% (OR 0.72)
⤵️ 💔 (OR 0.86)
⤵️ ☠️ (OR 0.77)
🔸 ⤵️⤵️ with human GLP-1 backbone
🥇Evidence across CKD stages—not just macroalbuminuria
👉 GLP-1 now a key 🎯 in CKD + #T2D
🔗 ggdocs.co/tnqomz
🔹 Meta-analysis of 18K pts w/ eGFR <60:
⤵️ eGFR decline ≥50% (OR 0.72)
⤵️ 💔 (OR 0.86)
⤵️ ☠️ (OR 0.77)
🔸 ⤵️⤵️ with human GLP-1 backbone
🥇Evidence across CKD stages—not just macroalbuminuria
👉 GLP-1 now a key 🎯 in CKD + #T2D
🔗 ggdocs.co/tnqomz
March 22, 2025 at 11:54 AM
📢 #GLP1 ⤵️ kidney decline, CV events & mortality in CKD❗️
🔹 Meta-analysis of 18K pts w/ eGFR <60:
⤵️ eGFR decline ≥50% (OR 0.72)
⤵️ 💔 (OR 0.86)
⤵️ ☠️ (OR 0.77)
🔸 ⤵️⤵️ with human GLP-1 backbone
🥇Evidence across CKD stages—not just macroalbuminuria
👉 GLP-1 now a key 🎯 in CKD + #T2D
🔗 ggdocs.co/tnqomz
🔹 Meta-analysis of 18K pts w/ eGFR <60:
⤵️ eGFR decline ≥50% (OR 0.72)
⤵️ 💔 (OR 0.86)
⤵️ ☠️ (OR 0.77)
🔸 ⤵️⤵️ with human GLP-1 backbone
🥇Evidence across CKD stages—not just macroalbuminuria
👉 GLP-1 now a key 🎯 in CKD + #T2D
🔗 ggdocs.co/tnqomz
Reposted by Neil Floch MD FACS FASMBS DABOM
🌍 Our real-world paper shows GLP1s are associated with lower risk of MACE & less costs than DPP4s or insulin in T2DM at higher CV risk 💔
link.springer.com/article/10.1...
@pccs.bsky.social @goggledocs.bsky.social @sabouretcardio.bsky.social @astonuniversity.bsky.social @swbhnhs.bsky.social
link.springer.com/article/10.1...
@pccs.bsky.social @goggledocs.bsky.social @sabouretcardio.bsky.social @astonuniversity.bsky.social @swbhnhs.bsky.social
Real-World Comparisons Between Glucagon-Like Peptide-1 Receptor Agonists and Other Glucose-Lowering Agents in Type 2 Diabetes: Retrospective Analyses of Cardiovascular and Economic Outcomes in England...
Introduction Clinical trials have demonstrated that glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes (T...
link.springer.com
March 22, 2025 at 9:05 PM
🌍 Our real-world paper shows GLP1s are associated with lower risk of MACE & less costs than DPP4s or insulin in T2DM at higher CV risk 💔
link.springer.com/article/10.1...
@pccs.bsky.social @goggledocs.bsky.social @sabouretcardio.bsky.social @astonuniversity.bsky.social @swbhnhs.bsky.social
link.springer.com/article/10.1...
@pccs.bsky.social @goggledocs.bsky.social @sabouretcardio.bsky.social @astonuniversity.bsky.social @swbhnhs.bsky.social
Reposted by Neil Floch MD FACS FASMBS DABOM
📢 Danuglipron dropped—can orforglipron still be the “oral GLP-1 that delivers”?
🔹 Pfizer halts danuglipron after liver signal
🔸 Orforglipron P2=HbA1c ⤵️2.1%, Wt ⤵️14.7%, no liver signal
🔹 P3 2025—will it safely deliver?
👉 Small molecule GLP-1: blockbuster or cautionary tale?
🔗 ggdocs.co/5qu8y3
🔹 Pfizer halts danuglipron after liver signal
🔸 Orforglipron P2=HbA1c ⤵️2.1%, Wt ⤵️14.7%, no liver signal
🔹 P3 2025—will it safely deliver?
👉 Small molecule GLP-1: blockbuster or cautionary tale?
🔗 ggdocs.co/5qu8y3
ggdocs.co
April 15, 2025 at 8:39 PM
📢 Danuglipron dropped—can orforglipron still be the “oral GLP-1 that delivers”?
🔹 Pfizer halts danuglipron after liver signal
🔸 Orforglipron P2=HbA1c ⤵️2.1%, Wt ⤵️14.7%, no liver signal
🔹 P3 2025—will it safely deliver?
👉 Small molecule GLP-1: blockbuster or cautionary tale?
🔗 ggdocs.co/5qu8y3
🔹 Pfizer halts danuglipron after liver signal
🔸 Orforglipron P2=HbA1c ⤵️2.1%, Wt ⤵️14.7%, no liver signal
🔹 P3 2025—will it safely deliver?
👉 Small molecule GLP-1: blockbuster or cautionary tale?
🔗 ggdocs.co/5qu8y3
Stress Eating and the Microbiome
Can you treat eating disorders with a #microbiome-friendly diet? www.psychologytoday.com/us/blog/mood...
Can you treat eating disorders with a #microbiome-friendly diet? www.psychologytoday.com/us/blog/mood...
Stress Eating and the Microbiome
Stress eating changes your gut microbes, which increases stress in a vicious cycle. By fixing your microbiome, you become more resilient, making it easier to gain back control.
www.psychologytoday.com
April 19, 2025 at 3:24 PM
Stress Eating and the Microbiome
Can you treat eating disorders with a #microbiome-friendly diet? www.psychologytoday.com/us/blog/mood...
Can you treat eating disorders with a #microbiome-friendly diet? www.psychologytoday.com/us/blog/mood...
Reposted by Neil Floch MD FACS FASMBS DABOM
What a fecal microbiota transplant lacks in glamour, it totally makes up for in efficacy.
scottcanderson.substack.com/p/a-surprisi...
scottcanderson.substack.com/p/a-surprisi...
A Surprising Fix for a Personality-Changing Liver Disease
“Our bodies have a finely tuned, built-in detoxifying system: It's called our liver, and it can detoxify our bodies better than any cleanse or fast.” —Harley Pasternak
scottcanderson.substack.com
April 18, 2025 at 3:06 PM
What a fecal microbiota transplant lacks in glamour, it totally makes up for in efficacy.
scottcanderson.substack.com/p/a-surprisi...
scottcanderson.substack.com/p/a-surprisi...
A message from @OMAsocial past PRESIDENT and #OAC board member @DrAngelaFitch:
IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to:
#betheHERO #betheHERO!
Cut the cost to $299 a month and Increase access to care!
IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to:
#betheHERO #betheHERO!
Cut the cost to $299 a month and Increase access to care!
April 12, 2025 at 12:20 AM
A message from @OMAsocial past PRESIDENT and #OAC board member @DrAngelaFitch:
IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to:
#betheHERO #betheHERO!
Cut the cost to $299 a month and Increase access to care!
IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to:
#betheHERO #betheHERO!
Cut the cost to $299 a month and Increase access to care!
Yes people are
Success people
Success people
April 3, 2025 at 1:23 PM
Yes people are
Success people
Success people
Reposted by Neil Floch MD FACS FASMBS DABOM
As bariatric surgery evolves to make the most of GLP-1 drugs, issues of when and how to use them for best results are a key focus: http://ms.spr.ly/63320qwot8
March 23, 2025 at 10:00 PM
As bariatric surgery evolves to make the most of GLP-1 drugs, issues of when and how to use them for best results are a key focus: http://ms.spr.ly/63320qwot8
Reposted by Neil Floch MD FACS FASMBS DABOM
There are a lot of errors in this misleading article. For instance… reducing the size of the stomach is only one way in which bariatric surgery works - it also increases GLP-1, PYY, and other gut hormones, reduces Ghrelin, increases blood bile acids, alters the microbiome among other benefits
The new weight loss drugs like Ozempic, Wegovy and Mounjaro are wildly popular for weight loss and are changing not just how people approach it, but what they then don't do instead, such as bariatric surgery. This doctor offers lots of important food for thought for anyone considering either.
Surgery or Meds: What’s the Best Approach to Weight Loss?
One may have better outcomes but the other can play a big role, and the decision depends on each person’s specific needs
medium.com
March 24, 2025 at 8:29 AM
There are a lot of errors in this misleading article. For instance… reducing the size of the stomach is only one way in which bariatric surgery works - it also increases GLP-1, PYY, and other gut hormones, reduces Ghrelin, increases blood bile acids, alters the microbiome among other benefits